Boston Private Financial Holdings, Inc. (BPFH) Touches $15.20 Formed H&S; Psychemedics (PMD) Sentiment Is 1.63

Boston Private Financial Holdings, Inc. (BPFH) formed inverse H&S with $15.81 target or 4.00% above today’s $15.20 share price. Boston Private Financial Holdings, Inc. (BPFH) has $1.28B valuation. The stock increased 1.67% or $0.25 during the last trading session, reaching $15.2. About 247,905 shares traded. Boston Private Financial Holdings, Inc. (NASDAQ:BPFH) has risen 23.13% since January 29, 2017 and is uptrending. It has outperformed by 6.43% the S&P500.

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company has market cap of $110.88 million. The companyÂ’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It has a 18.22 P/E ratio. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine.

Tieton Capital Management Llc holds 4.06% of its portfolio in Psychemedics Corporation for 256,359 shares. Moors & Cabot Inc. owns 337,060 shares or 0.9% of their US portfolio. Moreover, Carl Domino Inc has 0.25% invested in the company for 11,236 shares. The Illinois-based Ativo Capital Management Llc has invested 0.23% in the stock. North Star Investment Management Corp., a Illinois-based fund reported 78,271 shares.

The stock decreased 3.17% or $0.66 during the last trading session, reaching $20.19. About 11,906 shares traded. Psychemedics Corporation (PMD) has risen 66.72% since January 29, 2017 and is uptrending. It has outperformed by 50.02% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 1 sale for $154,029 activity.

Since January 22, 2018, it had 1 insider purchase, and 4 insider sales for $838,025 activity. MacDonald W. Timothy had bought 3,129 shares worth $48,312. The insider Higgins Martha sold $222,823. Waters Stephen M had sold 5,500 shares worth $85,303 on Monday, January 22. Morton John III sold $542,092 worth of Boston Private Financial Holdings, Inc. (NASDAQ:BPFH) on Monday, January 22. Shares for $36,119 were sold by Wells Donna.

Among 7 analysts covering Boston Private Financial Holdings (NASDAQ:BPFH), 0 have Buy rating, 0 Sell and 7 Hold. Therefore 0 are positive. Boston Private Financial Holdings has $1700 highest and $11 lowest target. $14.81’s average target is -2.57% below currents $15.2 stock price. Boston Private Financial Holdings had 25 analyst reports since July 17, 2015 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods on Thursday, January 18 with “Hold”. The company was maintained on Friday, November 17 by SunTrust. The stock of Boston Private Financial Holdings, Inc. (NASDAQ:BPFH) has “Hold” rating given on Thursday, June 8 by BMO Capital Markets. As per Tuesday, October 3, the company rating was maintained by Keefe Bruyette & Woods. As per Tuesday, October 3, the company rating was maintained by BMO Capital Markets. As per Friday, June 9, the company rating was maintained by Jefferies. BMO Capital Markets maintained the stock with “Hold” rating in Monday, December 18 report. On Thursday, December 21 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Jefferies downgraded the shares of BPFH in report on Monday, November 28 to “Hold” rating. The company was maintained on Friday, September 11 by RBC Capital Markets.